Front Range Biosciences, Inc. — Form D
Front Range Biosciences, Inc. of LAFAYETTE, CO, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-04. The offering totals $15.9M, of which $15.9M was reported sold. Industry: Other.
Offering
- Filed: 2018-10-04
- Form: D
- Accession: 0001689059-18-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $15.9M
- Amount sold: $15.9M
- Investors: 87
- Date of first sale: 2018-07-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-322805
Issuer
- Name: Front Range Biosciences, Inc.
- CIK: 0001689059
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 1724 MAJESTIC DR., LAFAYETTE, CO, 80026
- Phone: 617-320-8743
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Douglas Wolford | Director | Lafayette, CO |
| Nicholas Hofmeister | Promoter | LAFAYETTE, CO |
| Jonathan Vaught | Promoter | Lafayette, CO |
| Christopher Zalewski | Promoter | Lafayette, CO |
| Marc Riiska | Director | New York City, NY |
| William Militello | Director | Leesburg, VA |
| Ephraim Lindenbaum | Director | Campbell, CA |
| Nick Hofmeister | Director | Lafayette, CO |
| Nick Hofmeister | Executive Officer | Lafayette, CO |
| Nick Hofmeister | Promoter | Lafayette, CO |
| Jonathan Vaught | Director | Lafayette, CO |
| Jonathan Vaught | Executive Officer | Lafayette, CO |
| Nicholas Hofmeister | Director | LAFAYETTE, CO |
| Nicholas Hofmeister | Executive Officer | LAFAYETTE, CO |
| Christopher Zalewski | Director | Lafayette, CO |
| Christopher Zalewski | Executive Officer | Lafayette, CO |
Other filings by this issuer (6)
More